Patents by Inventor Steven M. MENNEN

Steven M. MENNEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salt of omecamtiv mecarbil and process for preparing salt
    Patent number: 11958809
    Abstract: Provided are omecamtiv mecarbil dihydrochloride salt forms, compositions and pharmaceutical formulations thereof, and methods for their preparation and use.
    Type: Grant
    Filed: September 24, 2021
    Date of Patent: April 16, 2024
    Assignee: CYTOKINETICS, INC.
    Inventors: Sheng Cui, Henry Morrison, Karthik Nagapudi, Shawn D. Walker, Charles Bernard, Karl Bennett Hansen, Neil Fred Langille, Alan Martin Allgeier, Steven M. Mennen, Jacqueline C. S. Woo, Bradley Paul Morgan, Alex Muci
  • POLYMORPHS AND COCRYSTALS OF A CARDIAC TROPONIN ACTIVATOR
    Publication number: 20220185790
    Abstract: Provided herein are free base crystalline forms, crystalline salts, solvates, amorphous free base, and cocrystals of Compound A.
    Type: Application
    Filed: March 12, 2020
    Publication date: June 16, 2022
    Inventors: Stephanie AZALI, Mary CHAVES, Ron C. KELLY, Steven M. MENNEN, Darren L. REID, Osama SULEIMAN, Ashraf WILSILY, Mark WRIGHT
  • SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SALT
    Publication number: 20220153700
    Abstract: Provided are omecamtiv mecarbil dihydrochloride salt forms, compositions and pharmaceutical formulations thereof, and methods for their preparation and use.
    Type: Application
    Filed: September 24, 2021
    Publication date: May 19, 2022
    Inventors: Sheng CUI, Henry MORRISON, Karthik NAGAPUDI, Shawn D. WALKER, Charles BERNARD, Karl Bennett HANSEN, Neil Fred LANGILLE, Alan Martin ALLGEIER, Steven M. MENNEN, Jacqueline C.S WOO, Bradley Paul MORGAN, Alex MUCI
  • METHOD OF REDUCING AROMATIC NITRO COMPOUNDS
    Publication number: 20220042055
    Abstract: A method for reducing a substrate selected from 2-methyl-5-nitropyridine and methyl 4-(2-fluoro-3-nitrobenzyl)piperazine-1-carboxylate is provided catalysed by a nitroreductase and a disproportionation agent.
    Type: Application
    Filed: December 12, 2019
    Publication date: February 10, 2022
    Inventors: Serena BISAGNI, Amin BORNADEL, Beatriz DOMINGUEZ, Jacques LEPAIH, Steven M. MENNEN, Ahir PUSHPANATH, Iustina SLABU, Jason TEDROW, Simon J. HEDLEY